Daily Dilution Report - Apr 15, 2026
All Events
$TLRY (MC: $799M)
- ATM Program: Up to $180M for up to 26.05M shares (at ~$6.91/share), 3.0% sales agent fee.
- Stock compensation plans: 303k options ($279.55 avg exercise), 5.84M RSUs, and 637k shares reserved for future issuance.
$GHM (MC: $1.0B)
- PIPE deal: 599,808 shares at $83.36/share, gross proceeds $50M.
- Investor: T. Rowe Price.
$CMRC (MC: $206M)
- Shareholder Rights Plan (Poison Pill) established to deter hostile takeovers; not a direct capital issuance.
- Grants rights to purchase Series A Junior Participating Preferred Stock; 500,000 shares reserved.
- Rights become exercisable upon 10% ownership threshold trigger; expire April 12, 2027.
$VREOF (MC: $445M)
- Warrants (Good Dog Holdings LLC): 80M shares exercisable @ $0.85/share.
- Direct Offering (Good Dog Holdings LLC): 213M shares issued @ $0.60/share (deemed value).
- ELOC: Good Dog Holdings LLC has participation rights to maintain ownership in future cash offerings.
$NUAI (MC: $244M)
- Warrants: 400,208 shares exercisable at ~$5.00.
- Direct Offering: 1,000,520 shares sold at ~$5.00.
- Underwriters' Option: 4,477,611 shares issued from prior offering.
$SAR (MC: $369M)
- Issued 7.25% Notes due 2029 (debt instruments).
- No direct stock dilution events from this issuance.
- No conversion features into common stock mentioned.
$SI (MC: $310M)
- The filing primarily discusses a lease agreement for a new corporate headquarters. It does not mention any issuance of warrants, convertible notes, convertible preferred stock, ATM programs, equity lines, direct offerings, PIPE deals, or stock compensation plans with reserved shares.
$HRZN (MC: $227M)
- The merger resulted in the issuance of approximately 20,370,693 shares of HRZN Common Stock to former MRCC stockholders. This is a significant increase in the share count, which can be considered dilutive to existing HRZN shareholders as their ownership percentage of the combined entity will be lower than their prior ownership percentage of HRZN alone. However, this is a consequence of the merger's share exchange ratio (0.9402 shares of HRZN for each MRCC share) and not a separate dilutive financing instrument.
$RMIX (MC: $306M)
- PIPE Investment totaling $167.1M for 17,378,756 Class A common shares and 2,525,094 pre-funded warrants.
- 26,000 shares of Series A Convertible Perpetual Preferred Stock issued; 398,800 Company Warrants issued, exercisable for Class A Common Stock.
- Additionally, 5,056,113 restricted Class A shares and 42.8M+ Class A/B common shares issued or converted to various parties.
$TBN (MC: $804M)
- Unregistered Sale of CDIs: A$37.1M for 741.5K underlying shares at A$0.25/CDI.
- Underwritten Offering Option Exercise: $14.7M for 443.5K shares.
- Registered Direct Entitlement Offer: 916.4K shares sold at $35.00/share, with additional closing expected.
$HYAC (MC: $314M)
- PIPE deals: 11.2M shares, 2.5M pre-funded warrants, & 6.1M shares issued to PIPE Investors prior to/at merger.
- 26,000 Series A Convertible Preferred Stock issued 4/8/2026.
- 50M shares authorized for 2026 Omnibus Incentive Plan.